Oral Cephalexin is the Preferred Step-Down Antibiotic After IV Cefazolin
For methicillin-susceptible Staphylococcus aureus (MSSA) infections, transition to oral cephalexin 500 mg every 6 hours (or 75-100 mg/kg/day divided into 3-4 doses for pediatrics) when the patient meets clinical stability criteria. 1, 2
Clinical Stability Criteria for Transition
Before switching to oral therapy, ensure the patient meets these four criteria 3:
- Improvement in infection-related symptoms (reduced pain, swelling, drainage)
- Afebrile (≤100°F) on two occasions 8 hours apart (though you may switch earlier if overall clinical response is favorable)
- Decreasing white blood cell count
- Functioning GI tract with adequate oral intake
Pathogen-Specific Oral Options
The choice depends on the suspected or confirmed pathogen:
For MSSA (Most Common with Cefazolin Use)
- First-line: Cephalexin 500 mg every 6 hours 1, 2
- Alternative: Clindamycin 300-600 mg every 8 hours (if susceptible) 4, 5
For MRSA (If Cultures Reveal This)
- Clindamycin 300-600 mg every 8 hours (if susceptibility confirmed and local resistance <10%) 4
- Trimethoprim-sulfamethoxazole 160-800 mg every 12 hours 4, 5
- Doxycycline 100 mg every 12 hours 4, 5
- Linezolid 600 mg every 12 hours (reserve for severe cases or resistance) 4, 5
For Streptococcal Infections
Important Caveats
Do NOT simply continue the same spectrum orally—this is "step-down" therapy where oral beta-lactams achieve lower serum levels than IV formulations, but this approach has proven clinically effective 3. The key is matching the oral agent to the pathogen's susceptibility profile.
If no pathogen is identified, cephalexin remains the logical choice as it maintains coverage for the most likely organisms (MSSA, streptococci) that cefazolin was targeting 1, 2.
Avoid these common pitfalls:
- Don't wait for complete normalization of inflammatory markers—clinical improvement is sufficient 3
- Don't keep patients hospitalized just to observe oral therapy—discharge the same day you switch if no other medical issues require admission 3
- Don't use rifampin as monotherapy or adjunctive therapy for skin/soft tissue infections 4
Duration of Oral Therapy
Continue oral antibiotics to complete the total treatment course appropriate for the infection type:
- Uncomplicated skin/soft tissue infections: 5-10 days total (including IV days) 4
- Complicated infections or bacteremia: Typically 2-6 weeks total depending on source control and clinical response 6, 7
Compliance is critical—choose once or twice daily dosing when possible to improve adherence, though cephalexin's four-times-daily dosing is necessary for adequate coverage 3.